An open-label single-arm phase II study of regorafenib for the treatment of angiosarcoma
| Autor: | Agulnik, Mark, Schulte, Brian, Robinson, Steven, Hirbe, Angela C., Kozak, Kevin, Chawla, Sant P., Attia, Steven, Rademaker, Alfred, Zhang, Hui, Abbinanti, Susan, Cehic, Rasima, Monga, Varun, Milhem, Mohammed, Okuno, Scott, Van Tine, Brian A. |
|---|---|
| Zdroj: | In European Journal of Cancer September 2021 154:201-208 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect